Navigation Links
CRF will Provide updates on several key cardiovascular trials at EuroPCR
Date:5/13/2014

NEW YORK, NY May 13, 2014 The Cardiovascular Research Foundation (CRF) will hold a special session providing updates on several key cardiovascular trials on Tuesday, May 20 at this year's EuroPCR meeting. The session will feature studies conducted by the CRF Clinical Trials Center, the academic research organization of CRF. EuroPCR will be held May 20-23, 2014 at the Palais Des Congrs de Paris in France.

Co-chaired by Gregg W. Stone, MD, Co-Director of the Medical Research & Education Division at CRF, and Ori Ben-Yehuda, MD, Executive Director of the CRF Clinical Trials Center, the session will present and discuss the latest investigations on vulnerable plaque, bioresorbable scaffolds, drug-eluting stents, antiplatelet medications, embolic protection stents, and mitral regurgitation.

"The session will focus on some of the most important trials currently in progress in the field of interventional cardiology," said Dr. Ben-Yehuda. "We are delighted to be presenting here at EuroPCR. Many of our studies are international and we work closely with our European colleagues in advancing the treatment of cardiovascular disease."

Planned and Ongoing Clinical Trials: A Status Update from the Cardiovascular Research Foundation
Tuesday, May 20, 3:20 4:20 PM
Room 253

PROSPECT II and PROSPECT ABSORB: Providing Regional Observations to Study Predictors of Events in the Coronary Tree
D. Erlinge

ABSORB IV: A Clinical Evaluation of Absorb Bioresorbable Vascular Scaffolds, the Everolimus-eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery lesions IV
G.W. Stone

HORIZONS-AMI II: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction II
G.W. Stone

MASTER II: MGuard Prime Stent System Clinical Trial in Patients with Acute STEMI II
G.W. Stone

COAPT: Cardiovascular Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients
G.W. Stone


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
3. Study of half siblings provides genetic clues to autism
4. Physicians mindfulness skills can improve care for patient and provider
5. Everyday fish oil capsule may provide kidney-related benefits
6. Partnership provides inclusive workout
7. 16th-century Korean mummy provides clue to hepatitis B virus genetic code
8. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
9. InsuranceCalculator.net Now Provides Competitive Car Insurance Quotes To Missouri Drivers
10. SEOMiracle.com Provides SEO Services with PayPal Verified Option
11. InsuranceCalculator.net Now Provides Competitive Car Insurance Quotes To Maryland Drivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may ... pelvic conditions and has helped many women become pregnant upon treating their diagnosis. ... office-based and simple outpatient evaluations. We can provide the necessary information to ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant ... produce more and better food, with fewer resources. It highlights the business’ principles, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... proud to announce that it has received 510(k) clearance from the U.S. Food ... and the MyoCycle Pro. , Both devices are stationary cycling systems that use ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  CVS Pharmacy, the retail division of CVS ... design to enhance the retail customer experience with ... and expanded beauty selections paired with informational signage ... offerings. Together with its innovative digital programs, these ... experience at CVS Pharmacy.  "Pharmacy ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: